Angiotensin in ECMO patients with refractory shock

by Marlies Ostermann, David W. Boldt, Michael D. Harper, George W. Lim, Kyle Gunnerson
Published 2018-11-01

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

by Kealy R. Ham, David W. Boldt, Michael T. McCurdy, Laurence W. Busse, Raphael Favory, Michelle N. Gong, Ashish K. Khanna, Stefan N. Chock, Feng Zeng, Lakhmir S. Chawla, George F. Tidmarsh, Marlies Ostermann
Published 2019-06-01